210 related articles for article (PubMed ID: 11452449)
1. [Novel diagnostic procedures for hematologic malignancies on the basis of genomic alterations].
Taniwaki M
Rinsho Ketsueki; 2001 May; 42(5):352-5. PubMed ID: 11452449
[No Abstract] [Full Text] [Related]
2. Impact of cytogenetic and molecular cytogenetic studies on hematologic malignancies.
Kolialexi A; Tsangaris GT; Kitsiou S; Kanavakis E; Mavrou A
Anticancer Res; 2005; 25(4):2979-83. PubMed ID: 16080555
[TBL] [Abstract][Full Text] [Related]
3. [Chromosomal analysis, fluorescence in situ hybridization method, and spectral karyotyping in hematologic malignancies].
Nara N
Rinsho Byori; 2003 Jun; Suppl 126():124-30. PubMed ID: 12905952
[No Abstract] [Full Text] [Related]
4. [Molecular diagnosis and new gene engineering in hematological malignancies].
Funato T; Fujiwara J; Fujimaki S; Kaku M
Rinsho Byori; 2000 Oct; 48(10):887-91. PubMed ID: 11215098
[TBL] [Abstract][Full Text] [Related]
5. FISH panels for hematologic malignancies.
Sreekantaiah C
Cytogenet Genome Res; 2007; 118(2-4):284-96. PubMed ID: 18000382
[TBL] [Abstract][Full Text] [Related]
6. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
[TBL] [Abstract][Full Text] [Related]
7. [Application of new FISH techniques for cytogenetic analysis in hematological malignancies].
Kakazu N; Abe T
Rinsho Ketsueki; 2002 May; 43(5):316-8. PubMed ID: 12096476
[No Abstract] [Full Text] [Related]
8. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
[TBL] [Abstract][Full Text] [Related]
9. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
Maciejewski JP; Tiu RV; O'Keefe C
Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
[TBL] [Abstract][Full Text] [Related]
10. Molecular cytogenetics.
Kearney L
Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
[TBL] [Abstract][Full Text] [Related]
11. Multicolor FISH.
Jalal SM; Law ME
Methods Mol Biol; 2002; 204():105-20. PubMed ID: 12397793
[No Abstract] [Full Text] [Related]
12. Screening for NUP98 rearrangements in hematopoietic malignancies by fluorescence in situ hybridization.
Nebral K; König M; Schmidt HH; Lutz D; Sperr WR; Kalwak K; Brugger S; Dworzak MN; Haas OA; Strehl S
Haematologica; 2005 Jun; 90(6):746-52. PubMed ID: 15951287
[TBL] [Abstract][Full Text] [Related]
13. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
14. [In situ hybridization techniques. Basis and applications in hematologic neoplasias].
Espinet B; Lloveras E; Solé F
Sangre (Barc); 1999 Aug; 44(4):261-7. PubMed ID: 10589277
[No Abstract] [Full Text] [Related]
15. [Value of molecular cytogenetics in pre- and postnatal diagnostic of chromosome abnormalities].
Romana SP; Gosset P; Elghezal H; Le Lorc'h M; Ozilou C; Lapierre JM; Sanlaville D; Brisset S; Turleau C; Vekemans M
J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1 Suppl):75-9. PubMed ID: 11240520
[No Abstract] [Full Text] [Related]
16. Applications of Fluorescence In Situ Hybridization Technology in Malignancies.
Tansatit M
Methods Mol Biol; 2017; 1541():75-90. PubMed ID: 27910016
[TBL] [Abstract][Full Text] [Related]
17. [Applications of fluorescence in situ hybridization in the study of hematologic neoplasms].
Hernández JM; Tabernero MD; García JL
Sangre (Barc); 1996 Aug; 41(4):305-9. PubMed ID: 8984672
[No Abstract] [Full Text] [Related]
18. Multicolor fluorescence in situ hybridization characterization of cytogenetically polyclonal hematologic malignancies.
Davidsson J; Paulsson K; Johansson B
Cancer Genet Cytogenet; 2005 Dec; 163(2):180-3. PubMed ID: 16337865
[TBL] [Abstract][Full Text] [Related]
19. Recurrent duplication of Xq27-qter in hematological malignancies revealed by multicolor fluorescence in situ hybridization and multicolor banding.
MacKinnon RN; Zordan A; Campbell LJ
Cancer Genet Cytogenet; 2005 Sep; 161(2):125-9. PubMed ID: 16102582
[TBL] [Abstract][Full Text] [Related]
20. [Various methods of chromosome abnormality detection by DNA technology].
Yamada K
Nihon Rinsho; 1999 Dec; 57 Suppl():632-7. PubMed ID: 10778209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
